-
1
-
-
0028907748
-
Evaluation of the performance of prednisone and salicylic acid calibrators
-
Achanta A.S., Gray V.A., Cecil T.L., Grady L.T. Evaluation of the performance of prednisone and salicylic acid calibrators. Drug Dev. Ind. Pharm. 21:1995;1171-1182.
-
(1995)
Drug Dev. Ind. Pharm.
, vol.21
, pp. 1171-1182
-
-
Achanta, A.S.1
Gray, V.A.2
Cecil, T.L.3
Grady, L.T.4
-
3
-
-
0020085526
-
Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere
-
Cox D.C., Wells C.E., Furman W.B., Savage T.S., King A.C. Systematic error associated with apparatus 2 of the USP dissolution test II: effects of deviations in vessel curvature from that of a sphere. J. Pharm. Sci. 71:1982;395-399.
-
(1982)
J. Pharm. Sci.
, vol.71
, pp. 395-399
-
-
Cox, D.C.1
Wells, C.E.2
Furman, W.B.3
Savage, T.S.4
King, A.C.5
-
4
-
-
0020519879
-
Systematic error associated with apparatus 2 of the USP dissolution test IV: Effect of air dissolved in the dissolution medium
-
Cox D.C., Furman W.B., Page D.P. Systematic error associated with apparatus 2 of the USP dissolution test IV: effect of air dissolved in the dissolution medium. J. Pharm. Sci. 72:1983;1061-1064.
-
(1983)
J. Pharm. Sci.
, vol.72
, pp. 1061-1064
-
-
Cox, D.C.1
Furman, W.B.2
Page, D.P.3
-
5
-
-
0021232978
-
Systematic error associated with apparatus 2 of the USP dissolution test V: Interaction of two tableted prednisone formulations with glass and plastic vessels
-
Cox D.C., Furman W.B. Systematic error associated with apparatus 2 of the USP dissolution test V: interaction of two tableted prednisone formulations with glass and plastic vessels. J. Pharm. Sci. 73:1984;1125-1127.
-
(1984)
J. Pharm. Sci.
, vol.73
, pp. 1125-1127
-
-
Cox, D.C.1
Furman, W.B.2
-
6
-
-
0031771036
-
Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets
-
Eddington N.D., Ashraf M., Augsburger L.L., Leslie J.L., Fossler M.J., Lesko L.J., Shah V.P., Rekhi G.S. Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets. Pharm. Dev. Technol. 3:1998;535-547.
-
(1998)
Pharm. Dev. Technol.
, vol.3
, pp. 535-547
-
-
Eddington, N.D.1
Ashraf, M.2
Augsburger, L.L.3
Leslie, J.L.4
Fossler, M.J.5
Lesko, L.J.6
Shah, V.P.7
Rekhi, G.S.8
-
8
-
-
0006967910
-
Industry perspective on dissolution apparatus calibration
-
McCormick T.J. Industry perspective on dissolution apparatus calibration. Dissolution Technol. 2:1995;12-15.
-
(1995)
Dissolution Technol.
, vol.2
, pp. 12-15
-
-
McCormick, T.J.1
-
9
-
-
0033775866
-
Evaluation of "external" predictability of an in vitro-in vivo correlation for an extended-release formulation containing metoprolol tartrate
-
Mahayni H., Rekhi G.S., Uppoor R.S., Marroum P., Hussain A.S., Augsburger L.L., Eddington N.D. Evaluation of "external" predictability of an in vitro-in vivo correlation for an extended-release formulation containing metoprolol tartrate. J. Pharm. Sci. 89:2000;1354-1361.
-
(2000)
J. Pharm. Sci.
, vol.89
, pp. 1354-1361
-
-
Mahayni, H.1
Rekhi, G.S.2
Uppoor, R.S.3
Marroum, P.4
Hussain, A.S.5
Augsburger, L.L.6
Eddington, N.D.7
-
10
-
-
0031871561
-
Lack of in vitro/in vivo correlations of 50 mg and 250 mg primidone tablets
-
Meyer M.C., Straughn A.B., Mhatre R.M., Shah V.P., Williams R.L., Lesko L.J. Lack of in vitro/in vivo correlations of 50 mg and 250 mg primidone tablets. Pharm. Res. 15:1998;1085-1089.
-
(1998)
Pharm. Res.
, vol.15
, pp. 1085-1089
-
-
Meyer, M.C.1
Straughn, A.B.2
Mhatre, R.M.3
Shah, V.P.4
Williams, R.L.5
Lesko, L.J.6
-
11
-
-
0006896685
-
Dissolution testing: Collaborative study of the in-house NCDA 2 dissolution calibrator tablets with USP apparatus 2
-
Moore T.W., Cox D.C. Dissolution testing: collaborative study of the in-house NCDA 2 dissolution calibrator tablets with USP apparatus 2. Pharmacopeial Forum. 23:1997;4250-4255.
-
(1997)
Pharmacopeial Forum
, vol.23
, pp. 4250-4255
-
-
Moore, T.W.1
Cox, D.C.2
-
13
-
-
0031739821
-
The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules
-
Piscitelli D.A., Bigora S., Propst C., Goskonda S., Schwartz P., Lesko L.J., Augsburger L., Young D. The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules. Pharm. Dev. Technol. 3:1998;443-452.
-
(1998)
Pharm. Dev. Technol.
, vol.3
, pp. 443-452
-
-
Piscitelli, D.A.1
Bigora, S.2
Propst, C.3
Goskonda, S.4
Schwartz, P.5
Lesko, L.J.6
Augsburger, L.7
Young, D.8
-
14
-
-
0030926727
-
Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets
-
Polli J.E., Rekhi G.S., Augsburger L.L., Shah V.P. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm. Sci. 86:1997;690-700.
-
(1997)
J. Pharm. Sci.
, vol.86
, pp. 690-700
-
-
Polli, J.E.1
Rekhi, G.S.2
Augsburger, L.L.3
Shah, V.P.4
-
15
-
-
0028898199
-
A critical assessment of the USP dissolution apparatus suitability test criteria
-
Qureshi S.A., McGilveray I.J. A critical assessment of the USP dissolution apparatus suitability test criteria. Drug Dev. Ind. Pharm. 21:1995;905-992.
-
(1995)
Drug Dev. Ind. Pharm.
, vol.21
, pp. 905-992
-
-
Qureshi, S.A.1
McGilveray, I.J.2
-
16
-
-
0032923660
-
Typical variability in drug dissolution testing: Study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product
-
Qureshi S.A., McGilveray S.A. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product. Eur. J. Pharm. Sci. 7:1999;249-258.
-
(1999)
Eur. J. Pharm. Sci.
, vol.7
, pp. 249-258
-
-
Qureshi, S.A.1
McGilveray, S.A.2
-
17
-
-
0033674245
-
Cause of high variability in drug dissolution testing and its impact on setting tolerance
-
Qureshi S.A., Shabnam J. Cause of high variability in drug dissolution testing and its impact on setting tolerance. Eur. J. Pharm. Sci. 12:2001;271-276.
-
(2001)
Eur. J. Pharm. Sci.
, vol.12
, pp. 271-276
-
-
Qureshi, S.A.1
Shabnam, J.2
-
18
-
-
0031401983
-
Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations
-
Rekhi G.S., Eddington N.D., Fossler M.J., Schwartz P., Lesko L.J., Augsburger L.L. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations. Pharm. Dev. Technol. 2:1997;11-24.
-
(1997)
Pharm. Dev. Technol.
, vol.2
, pp. 11-24
-
-
Rekhi, G.S.1
Eddington, N.D.2
Fossler, M.J.3
Schwartz, P.4
Lesko, L.J.5
Augsburger, L.L.6
-
19
-
-
85031141422
-
-
Rockville, MD: United States Pharmacopeial Convention
-
USP 25. 2002;2011-2012 United States Pharmacopeial Convention, Rockville, MD.
-
(2002)
USP 25
, pp. 2011-2012
-
-
-
20
-
-
85031143424
-
-
Rockville, MD: United States Pharmacopeial Convention
-
USP 25. 2002;133 United States Pharmacopeial Convention, Rockville, MD.
-
(2002)
USP 25
, pp. 133
-
-
-
21
-
-
85031136886
-
-
Rockville, MD: United States Pharmacopeial Convention
-
USP 25. 2002;165 United States Pharmacopeial Convention, Rockville, MD.
-
(2002)
USP 25
, pp. 165
-
-
-
22
-
-
85031139006
-
-
Rockville, MD: United States Pharmacopeial Convention
-
USP 25. 2002;302 United States Pharmacopeial Convention, Rockville, MD.
-
(2002)
USP 25
, pp. 302
-
-
|